Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia. (Q39601375)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M. Carmen Chillón

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

María Teresa Gómez Casares

5 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

María E Sarasquete

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Miguel Alcoceba

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Manuel Ramírez

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Marcos González Díaz

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

C E López-Jorge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

C Rodriguez-Medina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

A Molines

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

J D G-S Miguel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

C Bueno

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

R Montes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

F Ramos

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

J N Rodríguez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

P Giraldo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

R García-Delgado

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

J L Fuster

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

18 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

2360-2366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22705992%20AND%20SRC:MED&resulttype=core&format=json

Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

H3K79 methylation profiles define murine and human MLL-AF4 leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

FLT3 mutations in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

The roles of FLT3 in hematopoiesis and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Clinical relevance of FLT3 gene abnormalities in Brazilian patients with infant leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Human embryonic stem cells: A journey beyond cell replacement therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

7 January 2021

Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

7 January 2021

Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

7 January 2021

The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

7 January 2021

NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.161

7 January 2021